A detailed break-out of the company’s financial results shows its sports medicine product sales slumped this quarter, sitting at $56.7 million compared to $60.4 million in the same period in 2010. Other product sales, which consist principally of Coblation spine product sales, declined $0.5 million in Q1 of 2011 compared to the same period of 2010.
ArthroCare’s ENT product line, however, experienced a $2.6 million increase in sales.
Read the company news release about ArthroCare’s financial results.
Related Articles on Device Company Financial Results:
Greatbatch Orthopedic Line Sales Increase 34% to $39.6M
Zimmer Posts $1.12B in Q1 Net Sales, 5% Increase
MiMedx Q1 Revenues Up Following Surgical Biologics Acquisition
